← Leaderboards
Manish Sagar
Fred Hutchinson Cancer Research Center
$13,597,051
Attributed
$17,026,605
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,026,605 · 12
By mechanism
R01$10,939,442 · 4
R33$1,781,082 · 1
R21$941,575 · 2
K24$908,365 · 1
P30$902,416 · 1
R56$711,993 · 1
Top collaborators
- Suryaram Gummuluru5 shared
- Nina H. Lin5 shared
- Athe M. Tsibris2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsVirusPreventHiv-1Transmission ProcessInfectionAntibodiesChronicSamplingInflammationResponseBaseAntiretroviral TherapyVariantCharacteristicsInsightPropertyPlasmaReceptorTissuesMediatingFutureMorbidity - Disease RateT-Lymphocyte
Grant awards (40)
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission$1,407,828
R01 · FY2025 · AI · contact PI
Mycobacterium tuberculosis disease effect on HIV-1 immunity, evolution, and persistence$711,993
R56 · FY2025 · AI · contact PI
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission$703,914
R01 · FY2024 · AI · contact PI
The effects of opioid use on HIV-1 reservoir dynamics$883,605
R33 · FY2023 · DA
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission$703,914
R01 · FY2023 · AI · contact PI
HIV-1 mucosal transmission and persistence$181,673
K24 · FY2023 · AI · contact PI
The effects of opioid use on HIV-1 reservoir dynamics$897,477
R33 · FY2022 · DA
Persistent HIV expression induced type I IFN responses and inflammaging$771,666
R01 · FY2022 · AG
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission$699,829
R01 · FY2022 · AI · contact PI
Core H - Basic & Translational Sciences$255,591
P30 · FY2022 · AI · contact PI
Sartorious Octet R8 System$249,082
S10 · FY2022 · OD · contact PI
HIV-1 mucosal transmission and persistence$181,673
K24 · FY2022 · AI · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$778,565
R01 · FY2021 · AG
Core H - Basic & Translational Sciences$257,849
P30 · FY2021 · AI · contact PI
HIV-1 mucosal transmission and persistence$181,673
K24 · FY2021 · AI · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$742,299
R01 · FY2020 · AG
Core H - Basic & Translational Sciences$388,976
P30 · FY2020 · AI · contact PI
HIV-1 mucosal transmission and persistence$181,673
K24 · FY2020 · AI · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$737,535
R01 · FY2019 · AG
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$426,516
R01 · FY2019 · AI · contact PI
Identification and characterization of individuals with elite anti-HIV-1 ADCC$222,500
R21 · FY2019 · AI · contact PI
HIV-1 mucosal transmission and persistence$181,673
K24 · FY2019 · AI · contact PI
Persistent HIV expression induced type I IFN responses and inflammaging$778,455
R01 · FY2018 · AG
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$426,493
R01 · FY2018 · AI · contact PI
Identification and characterization of individuals with elite anti-HIV-1 ADCC$267,000
R21 · FY2018 · AI · contact PI
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$432,518
R01 · FY2017 · AI · contact PI
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$426,842
R01 · FY2016 · AI · contact PI
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$69,433
R01 · FY2016 · AI · contact PI
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract$445,716
R01 · FY2015 · AI · contact PI
Neutralizing and non-neutralizing antibodies protection from breast milk HIV-1$198,575
R21 · FY2013 · AI · contact PI
Neutralizing and non-neutralizing antibodies protection from breast milk HIV-1$253,500
R21 · FY2012 · AI · contact PI
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1$342,636
R01 · FY2011 · AI · contact PI
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1$346,097
R01 · FY2010 · AI · contact PI
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1$349,593
R01 · FY2009 · AI · contact PI
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1$349,593
R01 · FY2008 · AI · contact PI
The role of viral diversity in HIV-1 drug resistance$122,850
K08 · FY2006 · AI · contact PI
The role of viral diversity in HIV-1 drug resistance$122,850
K08 · FY2005 · AI
The role of viral diversity in HIV-1 drug resistance$122,850
K08 · FY2004 · AI
The role of viral diversity in HIV-1 drug resistance$112,050
K08 · FY2003 · AI
The role of viral diversity in HIV-1 drug resistance$112,050
K08 · FY2002 · AI